January 31, 2019
Takeda Pharmaceutical’s investigational live-attenuated tetravalent dengue vaccine TAK-003 was efficacious in preventing dengue fever caused by any of the four serotypes of the virus, an initial analysis of its ongoing multinational PIII study revealed. The vaccine was also well tolerated...read more